• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    67.27 +7.52 (+12.59%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    Why Is Moderna (MRNA) Stock Rocketing Higher Today
    What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 5.1% in the afternoon session after the stock's positive momentum was extended as... 
    Via StockStory
    Wednesday's session: top gainers and losers in the S&P500 index ↗
    Via Chartmill
    Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
    Via Investor Brand Network
    Curious about which S&P500 stocks are generating unusual volume on Monday? Find out below. ↗
    Via Chartmill
    NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 ↗
    It is finally bouncing back after several challenging years. 
    Via The Motley Fool
    News headline image
    Moderna to Present at Upcoming Conference in June 2026
    Via ACCESS Newswire
    What's going on in today's session: S&P500 gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
    Via ACCESS Newswire
    News headline image
    Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
    Via ACCESS Newswire
    News headline image
    Anterix Stock Is Up 140%. Here's Why One Investor Just Bought $15.8 Million ↗
    Anterix enables secure wireless communications for utilities and critical infrastructure through its nationwide 900 MHz spectrum portfolio. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Cash-Burning Stocks with Open Questions
    Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses... 
    Via StockStory
    Topics Bankruptcy
    News headline image
    2 Healthcare Stocks Worth Investigating and 1 Facing Headwinds
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t... 
    Via StockStory
    Stay informed with the top movers within the S&P500 index on Tuesday. ↗
    Via Chartmill
    What's going on in today's session: S&P500 gap up and gap down stocks ↗
    Via Chartmill
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
    Investors can find much better opportunities. 
    Via The Motley Fool
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    Gapping S&P500 stocks in Wednesday's session ↗
    Via Chartmill
    News headline image
    Moderna Recognized by TIME as One of the World's Most Impactful Companies
    Via ACCESS Newswire
    News headline image
    Stock Market Today, May 11: Chipmakers Drive Midday Gains Despite Oil Concerns ↗
    Today, May 11, 2026, AI chip leaders helped steady major U.S. indexes at midday as the Strait of Hormuz remains largely closed. 
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
    Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week. 
    Via The Motley Fool
    Topics Death
    CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
    Via Investor Brand Network
    InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
    Via Investor Brand Network
    Topics Intellectual Property
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    News headline image
    CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
    From BioMedWire
    Via GlobeNewswire
    News headline image
    3 Cash-Heavy Stocks with Warning Signs
    Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
    Via StockStory
    News headline image
    Moderna (MRNA) Shares Skyrocket, What You Need To Know
    What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 10.2% in the afternoon session after the company published positive Phase 3 clini... 
    Via StockStory
    Topics Intellectual Property
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.